Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 16 - Issue 6 - June 2019

Meeting Materials

FDA Panel
Confounders and Discrepancies: We Need More Rigorous Trials
06/29/2019
VDM talks with Prakash Krishnan, MD, FACC, from Mount Sinai Hospital, New York, New York. Dr. Krishan was the co-national primary investigator of the ILLUMENATE study.
VDM talks with Prakash Krishnan, MD, FACC, from Mount Sinai Hospital, New York, New York. Dr. Krishan was the co-national primary investigator of the ILLUMENATE study.
VDM talks with Prakash Krishnan,...
06/29/2019
Vascular Disease Management
FDA Panel
Drug-Coated Balloon Use Must Be Individualized to Our Patients
06/28/2019
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center, Mount Sinai Medical Center, Miami Beach, Florida.
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center, Mount Sinai Medical Center, Miami Beach, Florida.
VDM talks with Robert E....
06/28/2019
Vascular Disease Management
FDA Panel
The Future is Going to Be Drug-Coated or Drug-Eluting. We Need Individual Patient Data to Move Forward.
06/27/2019
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos...
06/27/2019
Vascular Disease Management
FDA Panel
Current Antiproliferative Considerations: The Eluvia Stent
06/25/2019
Steve Henao, MD, FACS, FACC, from New Mexico Heart Institute, Albuquerque, New Mexico, discusses the use of paclitaxel-coated devices to treat PAD.
Steve Henao, MD, FACS, FACC, from New Mexico Heart Institute, Albuquerque, New Mexico, discusses the use of paclitaxel-coated devices to treat PAD.
Steve Henao, MD, FACS, FACC,...
06/25/2019
Vascular Disease Management
FDA Panel
My View: Paclitaxel Use in Peripheral Arterial Disease
06/24/2019
Dr. Richard Heuser comments on the use of paclitaxel in peripheral arterial disease.
Dr. Richard Heuser comments on the use of paclitaxel in peripheral arterial disease.
Dr. Richard Heuser comments on...
06/24/2019
Vascular Disease Management
FDA Panel
Accepting the Risk of Treatment with Drug-Coated Balloons
06/22/2019
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New...
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New...
VDM talks with Frank J. Veith,...
06/22/2019
Vascular Disease Management
FDA Panel
A View on Drug-Coated Balloons From the Land of the Practicing Physician
06/21/2019
Jihad A. Mustapha, MD, comments on the use of drug-coated balloons.
Jihad A. Mustapha, MD, comments on the use of drug-coated balloons.
Jihad A. Mustapha, MD, comments...
06/21/2019
Vascular Disease Management
FDA Panel
Perspectives on the Use of Paclitaxel-Eluting Balloons in the Lower Extremities
06/20/2019
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina, regarding the FDA panel meeting that took place June 19th-20th, and his thoughts on drug-coated balloon use.
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina, regarding the FDA panel meeting that took place June 19th-20th, and his thoughts on drug-coated balloon use.
VDM talks with Daniel Clair, MD,...
06/20/2019
Vascular Disease Management

Feature

Case Report
Pedal Revascularization: Extending the Limits of Endovascular or Surgical Means to Prevent Amputation
06/29/2019
I this case, rather than opting for amputation in a patient with CLI not amenable to open bypass surgery or endovascular therapy, a novel open surgical approach was used to revascularize the pedal arteries.
I this case, rather than opting for amputation in a patient with CLI not amenable to open bypass surgery or endovascular therapy, a novel open surgical approach was used to revascularize the pedal arteries.
I this case, rather than opting...
06/29/2019
Vascular Disease Management
Case Report
Exotic Access for a Bilateral Above-Knee Amputee With Critical Limb Ischemia
06/14/2019
In the case herein, procedural success — defined by stenosis reduction and distal reperfusion of bilateral stumps — was dependent upon gaining arterial access through exotic techniques and crossing the CTOs.
In the case herein, procedural success — defined by stenosis reduction and distal reperfusion of bilateral stumps — was dependent upon gaining arterial access through exotic techniques and crossing the CTOs.
In the case herein, procedural...
06/14/2019
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

June 2019 Volume 16 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement